Elon Musk's Inner Circle Has Been Quietly Bankrolling the Psychedelic Renaissance
A Wall Street Journal investigation traces a network of SpaceX and Tesla insiders funding psychedelic research and drug development. Antonio Gracias — a SpaceX director and Valor Equity Partners founder — personally cut a $25 million check from his family foundation to recapitalize what's now Resilient Pharmaceuticals after its 2024 FDA rejection, then moved the company to Chicago and took it over — an idea reportedly pitched to him by MAPS founder Rick Doblin at a Burning Man gathering in 2024. Gracias also endowed a $16 million psychedelics-in-society professorship at Harvard back in 2023. Fellow SpaceX director Steve Jurvetson and his wife Genevieve — a board member of the Psychedelic Science Funders Collaborative — have long supported MDMA trial funding, and Kimbal Musk and his wife Christiana have backed a separate academic fellowship. Elon Musk himself has disclosed a ketamine prescription for depression and has spoken favorably about MDMA. The piece also connects the dots to the DoD's active-duty MDMA-PTSD trials and April's presidential executive order fast-tracking psychedelic drug review — which Trump has said Joe Rogan prompted him toward, specifically on ibogaine.
Read at The Times